Further Funding Announced to Support MCIP Flagship

Further Funding Announced to Support MCIP Flagship

Macmillan Cancer Support has committed an additional £2.2 million to the Macmillan Cancer Improvement Partnership (MCIP) in Manchester to enable the partnership to build on its pioneering work on improving cancer care in the city.

The announcement brings Macmillan’s total investment in MCIP to £5.65 million making it the charity’s largest single cancer care re-design in the UK.

The additional funding was approved after a series of major successes within the programme, such as a new palliative care service for North Manchester – and working with GPs and health care teams to develop the cancer care delivered by primary and community teams.

The latest funding will be used to deliver the improvement of Manchester’s breast and lung cancer care pathways.

MCIP, which was officially launched in June 2014, is a partnership of Macmillan, the three Manchester Clinical Commissioning Groups, people affected by cancer, GPs, NHS Hospital Trusts, St Ann’s Hospice and Manchester City Council. Its aim is to improve the experience of everybody affected by the disease at key points in the cancer journey. It does this by improving services based on the experiences of people affected by cancer.

MCIP Lung Cancer Lead Clinician, Dr Phil Barber said:

“We very much welcome the continued development of the MCIP lung project into a third phase. This will enable us to fully operationalize our work on early detection to implement a radical shortening of the investigative pathway, and to continue to improve the overall quality of the patient experience with a special focus on rapid access to specialist care in the community.

Raising awareness of  lung cancer as a preventable and potentially curable condition is also vital for success in making a real impact on Manchester’s biggest cancer killer.”

Macmillan Cancer Support’s Interim Director of England, Fay Scullion said:

“MCIP’s aims of improving cancer care have always been bold and ambitious because patients and carers in Manchester deserve better cancer care, earlier diagnosis, improved palliative and end of life care, and support throughout the entire cancer journey.

We have seen some extraordinary successes implemented by MCIP through Macmillan’s initial investments totalling £3.45 million. We cannot lose the impetus of this transformational work, which is why Macmillan has today committed to invest a further £2.2 million to ensure MCIP can deliver on its ambitions for cancer patients and carers in Manchester.”

South Manchester Clinical Commissioning Group Chief Officer and MCIP Board Chair, Caroline Kurzeja said: “This further investment of £2.2 million is a huge endorsement of the work that MCIP has achieved. The partnership is having a clear impact on primary, palliative and end of life care across the city – and a vast amount of work has gone into training health care teams so that they can better support patients and carers.

“These additional funds will be used to bring to fruition MCIP’s exciting plans for breast and lung cancer care.”

Among MCIP’s achievements to date are:

  • The introduction of the MCIP Locally Commissioned Service – signed up to by 90 per cent of the city’s GP practices – and which provides cancer training for GPs and practice staff; created Cancer Champions within practices; Macmillan Infopoints in all practices; support to improve Cancer Care Reviews, palliative care and early diagnosis.
  • Introduction of the North Manchester Macmillan Palliative Care Support Service, providing a seven-days-a-week dedicated team of care professionals; a 24-hour telephone advice line; extra help at home; greater choice over where care is delivered.
  •  Development of a cancer training programme for general community care staff so that they can help their clients with cancer concerns and support them before, during and after treatment.
  • Appointment of four Quality Improvement Facilitators within the four major Manchester hospitals to help implement MCIP’s work on improving  early diagnosis; aftercare and support; and treatment pathways for patients with primary and advanced breast and lung cancers.
  • The recruitment and inclusion of more than 50 volunteers who work with the MCIP team, sitting on the MCIP Board and working groups, as well as helping with outreach activities and communication and engagement activities.
  • The creation of a series of ‘Cancer and You’ information and engagement events throughout Manchester, as well as participation in dozens of existing community events where MCIP’s work is communicated to patients and carers.

ENDS

MEDIA CONTACT: Michelle O’Leary MCIP Communications Lead 07787 375 172

Connect with us